Urine Proteome of Patients Having Surgery

This study is currently recruiting participants.

Verified December 2012 by Washington University School of Medicine

Sponsor:

Information provided by (Responsible Party):

Washington University School of Medicine

ClinicalTrials.gov Identifier:

NCT00851994

First received: February 25, 2009

Last updated: December 4, 2012

Last verified: December 2012

History of Changes

Purpose

The investigators are measuring novel proteins in the urine of patients having surgery.

Condition
Surgery

Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	Urine Proteome of Patients Undergoing Surgery

Resource links provided by NLM:

MedlinePlus related topics: Urine and Urination

U.S. FDA Resources

Further study details as provided by Washington University School of Medicine:

Primary Outcome Measures:

Changes in urine proteins after surgery. [ Time Frame: Pre-op, intraoperative, post operatively (1-6 months) ] [ Designated as safety issue: No ]

Biospecimen Retention: Samples With DNA

We are collecting urine and blood samples.

Estimated Enrollment:	275
Study Start Date:	July 2008
Estimated Study Completion Date:	June 2014
Estimated Primary Completion Date:	June 2013 (Final data collection date for primary outcome measure)

Groups/Cohorts
1 Patients having surgery

Eligibility

Ages Eligible for Study:	19 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients having surgery.

Criteria

Inclusion Criteria:

Patients > 18 years of age
Undergoing surgery

Exclusion Criteria:

No formal exclusion criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00851994

Locations

United States, Missouri
Barnes Jewish Hospital	Recruiting
St. Louis, Missouri, United States, 63110
Contact: Jerry Morrissey, PhD 314-454-7464 morrisse@wustl.edu
Principal Investigator: Jerry Morrissey, PhD

Sponsors and Collaborators

Washington University School of Medicine

Investigators

Principal Investigator:

Jerry Morrissey, PhD

Washington University School of Medicine

More Information

No publications provided by Washington University School of Medicine

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Morrissey JJ, London AN, Lambert MC, Kharasch ED. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma. Am J Nephrol. 2011;34(5):391-8. Epub 2011 Sep 7.

Morrissey JJ, London AN, Luo J, Kharasch ED. Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin Proc. 2010 May;85(5):413-21. Epub 2010 Apr 7.

Responsible Party:	Washington University School of Medicine
ClinicalTrials.gov Identifier:	NCT00851994 History of Changes
Other Study ID Numbers:	08-0458
Study First Received:	February 25, 2009
Last Updated:	December 4, 2012
Health Authority:	United States: Institutional Review Board

Keywords provided by Washington University School of Medicine:

Patients having surgery

ClinicalTrials.gov processed this record on May 19, 2013

To Top